Patritumab Biosimilar – Anti-ERBB3 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product namePatritumab Biosimilar - Anti-ERBB3 mAb - Research Grade
SourceCAS 1262787-83-6
SpeciesHomo sapiens
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPatritumab,AMG888,U3-1287,ERBB3,anti-ERBB3
ReferencePX-TA1284
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Patritumab Biosimilar - Anti-ERBB3 mAb - Research Grade

General information on Anti-ERBB3[Homo sapiens] (Patritumab) Monoclonal Antibody

Patritumab has been investigated for the treatment of Lung Cancer, Solid Tumors, Neoplasms by Site, Head and Neck Neoplasms.

SDS-PAGE for Patritumab Biosimilar - Anti-ERBB3 mAb

Patritumab Biosimilar - Anti-ERBB3 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Patritumab Biosimilar – Anti-ERBB3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag
Antigen

Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag

PX-P4725 250$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products